Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sahzene Yavuz"'
Autor:
Shanshan Chen, George F. Wohlford, Alessandra Vecchie’, Salvatore Carbone, Sahzene Yavuz, Benjamin Van Tassell, Antonio Abbate, Francesco S. Celi
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
ContextThe pharmacokinetics of liothyronine causes concerns for cardiovascular toxicity. While the effects of sustained increase in serum T3 concentrations are well described, little is known on the effects of acute changes in T3 concentrations due t
Externí odkaz:
https://doaj.org/article/5d6ed8d194f2410f9c01088260fc6029
Publikováno v:
Journal of Clinical and Translational Endocrinology Case Reports, Vol 19, Iss , Pp 100080- (2021)
Pituitary metastasis is a rare manifestation of systemic malignancy accounting for approximately 1% of all pituitary tumors. Breast and lung tumors are the most common primary sources of metastases, yet other sites such as the gastrointestinal tract,
Externí odkaz:
https://doaj.org/article/602dbbbb91d74204b0fbda93968fc188
Publikováno v:
Frontiers in Endocrinology, Vol 10 (2020)
Thyroid dysfunction, either thyrotoxicosis or hypothyroidism, represents an important cardiovascular risk factor. Heart disease is the leading cause of death for men and women in the United States. Cardiovascular disease is multifactorial and many ef
Externí odkaz:
https://doaj.org/article/bf6d392f274f4be8ab334da88a8dfc28
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 230-234 (2017)
Programmed cell death-1 (PD-1) ligand inhibitors have gained popularity in the treatment of advanced non-small-cell lung cancer. The immune system is regulated by stimulatory and inhibitory signaling and aims to achieve the balance between activation
Externí odkaz:
https://doaj.org/article/3fb50f9a69f84ca1a2f025ab3b6e40ea
Autor:
Sheila Smith, Joyce D. Linderman, Van Tassell B, Wohlford Gf th, Francesco S. Celi, Sahzene Yavuz, F. M. Pucino
Publikováno v:
Thyroid
Background: L-triiodothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer (TC) patients during the preparation for nuclear medicine procedures, and it is used in combination with LT4 in patients who do not respond to the standar
Publikováno v:
Journal of the Endocrine Society
Energy metabolism is one of the most recognized targets of thyroid hormone action, which indeed plays a critical role in modulating energy expenditure in all of its components. This is because thyroid hormone receptors are ubiquitous, and thyroid hor
Publikováno v:
Journal of Clinical and Translational Endocrinology Case Reports, Vol 19, Iss, Pp 100080-(2021)
Pituitary metastasis is a rare manifestation of systemic malignancy accounting for approximately 1% of all pituitary tumors. Breast and lung tumors are the most common primary sources of metastases, yet other sites such as the gastrointestinal tract,
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 1, Pp 230-234 (2017)
Case Reports in Oncology
Case Reports in Oncology
Programmed cell death-1 (PD-1) ligand inhibitors have gained popularity in the treatment of advanced non-small-cell lung cancer. The immune system is regulated by stimulatory and inhibitory signaling and aims to achieve the balance between activation
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 10 (2020)
Frontiers in Endocrinology, Vol 10 (2020)
Thyroid dysfunction, either thyrotoxicosis or hypothyroidism, represents an important cardiovascular risk factor. Heart disease is the leading cause of death for men and women in the United States. Cardiovascular disease is multifactorial and many ef
Autor:
George F. Wohlford, Sheila Smith, Joyce D. Linderman, Frank Pucino, Francesco S. Celi, Sahzene Yavuz, Benjamin W. Van Tassell
Publikováno v:
Journal of the Endocrine Society
Background Liothyronine (LT3) is a substitute for levothyroxine (LT4) for thyroid cancer patients during the preparation for nuclear medicine procedures, and there is renewed interest in its use in combination with LT4 in patients who do not respond